APLS — APELLIS PHARMACEUTICALS INC

Ownership history in SPHERA FUNDS MANAGEMENT LTD.  ·  9 quarters on record

This page tracks every 13F SEC filing in which SPHERA FUNDS MANAGEMENT LTD. reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.22% (2025 Q4)
Avg. % of fund
0.67%
First filed
2018 Q2
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 250,961 +187,301 +294.2% 1.22% $6.3M $25.12
2025 Q3 REDUCED 63,660 -50,686 -44.3% 0.30% $1.4M $22.63
2025 Q2 REDUCED 114,346 -67,000 -36.9% 0.46% $2.0M $17.31
2025 Q1 REDUCED 181,346 -24,905 -12.1% 0.91% $4.0M $21.87
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% HighVista Strategies LLC 3Y 7Y 0.98%
← Back to SPHERA FUNDS MANAGEMENT LTD. Holdings